7c8l: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "7c8l" [edit=sysop:move=sysop] |
No edit summary |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Hybrid designing of potent inhibitors of Striga strigolactone receptor ShHTL7== | |||
<StructureSection load='7c8l' size='340' side='right'caption='[[7c8l]], [[Resolution|resolution]] 1.45Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7C8L OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7C8L FirstGlance]. <br> | |||
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.45Å</td></tr> | |||
[[Category: | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EGC:2-(2-{2-[2-(2-{2-[2-(2-{2-[4-(1,1,3,3-TETRAMETHYL-BUTYL)-PHENOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHANOL'>EGC</scene>, <scene name='pdbligand=FP6:PYRROLIDINE-1-CARBALDEHYDE'>FP6</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | ||
[[Category: | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7c8l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7c8l OCA], [https://pdbe.org/7c8l PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7c8l RCSB], [https://www.ebi.ac.uk/pdbsum/7c8l PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7c8l ProSAT]</span></td></tr> | ||
[[Category: | </table> | ||
__TOC__ | |||
</StructureSection> | |||
[[Category: Large Structures]] | |||
[[Category: Arold ST]] | |||
[[Category: Shahul Hameed UF]] | |||
Latest revision as of 11:25, 30 October 2024
Hybrid designing of potent inhibitors of Striga strigolactone receptor ShHTL7
| ||||||||||||